Legato Capital Management LLC Makes New $778,000 Investment in HealthEquity, Inc. (NASDAQ:HQY)

Legato Capital Management LLC bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the fourth quarter, HoldingsChannel.com reports. The firm bought 8,110 shares of the company’s stock, valued at approximately $778,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. UMB Bank n.a. raised its stake in HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after acquiring an additional 164 shares during the period. Quarry LP raised its stake in HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after acquiring an additional 1,089 shares during the period. 1620 Investment Advisors Inc. bought a new stake in HealthEquity during the 3rd quarter worth approximately $112,000. GAMMA Investing LLC grew its holdings in HealthEquity by 32.9% during the 4th quarter. GAMMA Investing LLC now owns 1,248 shares of the company’s stock valued at $120,000 after buying an additional 309 shares in the last quarter. Finally, Covestor Ltd grew its holdings in HealthEquity by 27.4% during the 3rd quarter. Covestor Ltd now owns 1,524 shares of the company’s stock valued at $125,000 after buying an additional 328 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of HealthEquity stock opened at $113.94 on Friday. The stock has a market cap of $9.87 billion, a price-to-earnings ratio of 104.53, a price-to-earnings-growth ratio of 1.61 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a 50 day moving average price of $101.90 and a 200-day moving average price of $90.53. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the previous year, the business earned $0.40 EPS. Equities analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on HQY shares. BTIG Research increased their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Barrington Research increased their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Monday, December 2nd. Bank of America increased their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. Mizuho started coverage on shares of HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective for the company. Finally, The Goldman Sachs Group started coverage on shares of HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and an average price target of $110.71.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the completion of the transaction, the director now owns 66,469 shares in the company, valued at $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 39,000 shares of company stock worth $3,895,788. Insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.